Tue. Aug 9th, 2022
Govt Approves Oxford Vaccine For India

In a major development, the Indian Government has now approved the covid-19 vaccine developed by Oxford University and AstraZeneca for emergency use in India.

This means that all Indians will be able to get a coronavirus¬†vaccine called “Covishield” and the first shot will be given by 10 January.

Oxford Vaccine Approved In India

The Central Drugs Standard Control Organization (CDSCO) has approved the emergency use of the Covishield vaccine in India, developed by Oxford and AstraZeneca, and produced by the Serum Institute in Pune.

The final approval of the Drugs Controller General of India (DCGI) is anticipated, after which the mass vaccination program will begin to vaccinate 30 Crore Indians in the first phase.

As reported, the other vaccine developed by Bharat Biotech is still in the testing stage, and Gov. asked for more details on their vaccine prior to approval.

In this way, India became the third nation after the UK and Argentina to approve the Oxford vaccine, which reportedly had a success rate of 90% in clinical trials.

Rules For Covid-19 Vaccination

Government decided to offer priority to 30 Crore Indians who are front-line workers, such as health professionals, sanitation workers, police officers, and all government or private employees who are directly interacting and serving clients.

  • All the persons getting the vaccine will be provided with information about the covid-19 vaccine
  • The vaccinated person will be asked to report any adverse effect in every 15 days
  • 2 doses will be provided, in a gap of 4-6 weeks

The Serum Institute has established an approximate cost of Rs 200-225 per dose and the cost of the first 10 crore doses will be borne by the PM Care Fund.

By gnews

Leave a Reply

Your email address will not be published.